Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ATG-101 by Antengene for Colon Cancer: Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Colon Cancer. According to GlobalData, Phase I...
ATG-101 by Antengene for Cervical Cancer: Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
ATG-101 by Antengene for Gastric Cancer: Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
ATG-101 by Antengene for Glioblastoma Multiforme (GBM): Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
ATG-101 by Antengene for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....
ATG-101 by Antengene for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
ATG-101 is under clinical development by Antengene and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...